Related Experiment Video
Updated: Jul 11, 2026
08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Covariate analysis of viral eradication studies
1Department of Biostatistics, Harvard University School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA. dcheng@hsph.harvard.edu
Biostatistics (Oxford, England)
|August 23, 2003
Summary
This study introduces a new statistical model to analyze viral eradication and resistance in hepatitis C and HIV therapeutic trials. The model accounts for unobservable eradication events, improving covariate analysis in clinical data.
Area of Science:
- Biostatistics
- Viral Hepatitis Research
- Retroviral Research
Background:
- Viral eradication and resistance are critical outcomes in hepatitis C and HIV therapeutics.
- Analyzing these outcomes is challenging due to unobservable eradication events and unique censoring patterns.
- Existing statistical methods may not adequately address the complexities of occult events in competing risks settings.
Purpose of the Study:
- To propose a novel semiparametric regression model for assessing covariate associations with viral eradication and resistance.
- To develop methods that can handle unique censored observations arising from occult eradication events.
- To provide a robust analytical framework for therapeutic studies involving hepatitis C and HIV.
Main Methods:
- Development of a piecewise proportional hazards model.
- The model allows for time-varying parameters to capture dynamic covariate effects.
- Application of the proposed semiparametric regression to real-world clinical trial data.
Main Results:
- The proposed model effectively assesses the association between multiple covariates and viral eradication/resistance processes.
- Demonstrated utility in analyzing complex censored data from hepatitis C clinical trials.
- The piecewise proportional hazards approach provides flexibility in modeling time-dependent effects.
Conclusions:
- The developed semiparametric regression model offers a valuable tool for analyzing viral eradication and resistance in infectious disease clinical trials.
- The methods are particularly useful for studies where key events are not directly observed.
- This approach enhances the understanding of factors influencing treatment outcomes in hepatitis C and HIV.
More Related Videos
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
05:49Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
Published on: November 21, 2023
Related Concept Videos
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:21Causality in Epidemiology
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
01:27Confounding in Epidemiological Studies
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
01:29Bias in Epidemiological Studies
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...